Date Filed | Type | Description |
08/01/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
05/19/2023 |
4
| Ashton William (Director) has filed a Form 4 on Societal CDMO, Inc.
Txns:
| Granted 73,620 shares
@ $0 Granted 27,229 options to buy
@ $0.74, valued at
$20.1k
|
|
09/02/2022 |
4
| Ashton William (Director) has filed a Form 4 on SPECTRUM PHARMACEUTICALS INC
Txns:
| Granted 25,000 shares
@ $0 Granted 75,000 options to buy
@ $1.13, valued at
$84.8k
|
|
06/22/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
06/17/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
05/20/2022 |
4
| Ashton William (Director) has filed a Form 4 on Societal CDMO, Inc.
Txns:
| Granted 87,500 shares
@ $0 Granted 118,182 options to buy
@ $0.8, valued at
$94.5k
|
|
06/22/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
05/17/2021 |
4/A
| Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] |
04/22/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
04/08/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
06/23/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
06/19/2020 |
4
| Ashton William (Director) has filed a Form 4 on SPECTRUM PHARMACEUTICALS INC
Txns:
| Granted 30,000 shares
@ $0 Granted 60,000 options to buy
@ $2.94, valued at
$176.4k
|
|
05/11/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
05/08/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
12/09/2019 |
4
| Ashton William (Director) has filed a Form 4 on Recro Pharma, Inc.
Txns:
| Granted 17,582 shares
@ $0 |
|
12/09/2019 |
4
| Ashton William (Director) has filed a Form 4 on Baudax Bio, Inc.
Txns:
| Granted 20,000 shares
@ $0 |
|
12/02/2019 |
3
| Ashton William (Director) has filed a Form 3 on Baudax Bio, Inc. |
06/21/2019 |
4
| Ashton William (Director) has filed a Form 4 on SPECTRUM PHARMACEUTICALS INC
Txns:
| Sold 5,000 shares
@ $8.59, valued at
$43k
Sold 1,667 shares
@ $8.5, valued at
$14.2k
Granted 10,000 shares
@ $0 Granted 20,000 options to buy
@ $8.44, valued at
$168.8k
|
|
05/10/2019 |
4
| Ashton William (Director) has filed a Form 4 on Recro Pharma, Inc.
Txns:
| Granted 7,955 shares
@ $0 Granted 10,888 options to buy
@ $8.8, valued at
$95.8k
|
|
12/03/2018 |
4
| Ashton William (Director) has filed a Form 4 on SPECTRUM PHARMACEUTICALS INC
Txns:
| Granted 3,333 shares
@ $0 Granted 6,667 options to buy
@ $14.02, valued at
$93.5k
|
|
06/19/2018 |
4
| Ashton William (Director) has filed a Form 4 on SPECTRUM PHARMACEUTICALS INC
Txns:
| Granted 10,000 shares
@ $0 Granted 20,000 options to buy
@ $19.95, valued at
$399k
|
|
05/14/2018 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
05/10/2018 |
4/A
| Ashton William (Director) has filed a Form 4 on Recro Pharma, Inc.
Txns:
| Granted 8,965 options to buy
@ $11.32, valued at
$101.5k
|
|
05/08/2018 |
4
| Ashton William (Director) has filed a Form 4 on Recro Pharma, Inc.
Txns:
| Granted 6,183 shares
@ $0 Granted 5,742 options to buy
@ $11.32, valued at
$65k
|
|
03/05/2018 |
3
| Ashton William (Director) has filed a Form 3 on SPECTRUM PHARMACEUTICALS INC |
10/10/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
07/06/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
05/16/2017 |
4
| Ashton William (Director) has filed a Form 4 on Recro Pharma, Inc. |
04/12/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
01/24/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
07/18/2016 |
4
| Ashton William (Director) has filed a Form 4 on Galena Biopharma, Inc.
Txns:
| Granted 100,000 options to buy
@ $0.41, valued at
$41k
|
|
12/18/2015 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
06/23/2015 |
4
| Ashton William (Director) has filed a Form 4 on Galena Biopharma, Inc.
Txns:
| Granted 100,000 options to buy
@ $1.77, valued at
$177k
|
|
03/18/2015 |
4
| Ashton William (Director) has filed a Form 4 on Sucampo Pharmaceuticals, Inc.
Txns:
| Sold 30,000 shares
@ $17.32, valued at
$519.6k
Sold 20,000 shares
@ $17.32, valued at
$346.4k
Sold 9,600 shares
@ $17.32, valued at
$166.3k
Sold 13,500 shares
@ $17.32, valued at
$233.8k
Sold 904 shares
@ $17.32, valued at
$15.7k
Sold 19,096 shares
@ $17.55, valued at
$335.1k
Sold 20,000 shares
@ $17.55, valued at
$351k
Sold 16,666 shares
@ $17.55, valued at
$292.5k
Exercised 30,000 options to buy
@ $4.99, valued at
$149.7k
Exercised 20,000 options to buy
@ $3.56, valued at
$71.2k
Exercised 9,600 options to buy
@ $4.41, valued at
$42.3k
|
|
|